VolitionRX Ltd (VNRX) Financials

VNRX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 8.3 million 41.8 million
March 31, 2026 9.0 million 42.4 million
Dec. 31, 2025 6.9 million 42.5 million
Sept. 30, 2025 6.4 million 42.4 million

VNRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -5.2 million 238004
March 31, 2026 -5.3 million 224981
Dec. 31, 2025 -5.5 million -132875
Sept. 30, 2025 -3.5 million 609167

VNRX Net Income

No data available :(

VNRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 2.8 million - -
March 31, 2026 3.1 million - 810872
Dec. 31, 2025 1.1 million - 899130
Sept. 30, 2025 199407 - 991425

VNRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 9.2 million
March 31, 2026 6.9 million
Dec. 31, 2025 5.3 million
Sept. 30, 2025 5.4 million

VNRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1788 1.8 million 2.2 million 548513
March 31, 2026 9214 2.9 million 2.6 million 851851
Dec. 31, 2025 10967 2.5 million 2.5 million 233675
Sept. 30, 2025 1178 2.3 million 3.2 million 213364

VNRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 398657 -
March 31, 2026 985076 254411
Dec. 31, 2025 447034 -
Sept. 30, 2025 627277 -

VNRX

Price: $0.34

52 week price:
0.33
15.20

Earnings Per Share: -3.96 USD

Exchange: ASE

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 202636

Market Capitalization: 6.7 million

Links: